CME Challenges CFTC Over Bitcoin Perpetuals, Saying They’re Swaps Under Dodd-Frank

CME Group is taking the gloves off. Outgoing CEO Terry Duffy said on CNBC’s Fast Money that the company will sue the Commodity Futures Trading Commission on Thursday over its recent approvals allowing crypto perpetual futures to reach U.S. traders. The move follows late-May clearances for prediction market Kalshi to list a Bitcoin perpetual futures contract and for Coinbase to connect U.S. customers to offshore perps—marking the first time these instruments are available through domestic regulated venues. CME later confirmed the litigation plan to Reuters.

The dispute sits on a definitional fault line. Duffy argues perpetual futures are, in substance, swaps under the Dodd-Frank Act rather than futures, because they rely on ongoing payments between counterparties. That classification would push the products into a different regulatory lane—implicating swap execution facilities, distinct clearing and reporting requirements, and a tighter compliance perimeter. He also flagged CME’s exclusive licenses on core market benchmarks, implying rival perp venues might still have to interface with CME infrastructure. Duffy further criticized the speed of the agency’s review, calling out an accelerated path for a novel instrument.

Perpetual futures—perps—are non-expiring derivatives that anchor to spot via funding payments, not via monthly expiries. Leverage can run as high as 50-to-1, which amplifies both profit and loss and makes margin models and liquidation engines central to risk control. CFTC Chair Michael Selig has defended the approvals as a way to bring one of crypto’s most liquid markets onshore. A Commission spokesperson told Reuters the agency looks forward to addressing the claims and called the lawsuit “frivolous.”

Here’s the crux: the funding leg that keeps perps tethered to spot looks a lot like a stream of payments—swap-like—while the exchange-traded, centrally cleared wrapper feels future-like. Where a court lands will shape market structure. If that periodic payment mechanism defines the instrument, perps could be driven onto swap venues with different participant obligations and clearing standards. If the exchange-traded form and continuous mark-to-market take precedence, futures rules stand, opening the door for broader DCM-based perp listings.

The technical design matters. Funding rates depend on index quality, oracle stability, and fair-price marks; those mechanisms can misfire under stress, creating reflexive liquidations. Onshore venues will need transparent funding calculations and robust circuit breakers to prevent the kind of cascading moves seen offshore. The behavioral tilt is clear: domestic branding and regulatory badges often reduce perceived risk, which can encourage higher leverage usage precisely when volatility spikes. That’s why Duffy’s broader warning—comparing current speculation to the run-up before 2008 and suggesting a disaster could be forming—shouldn’t be dismissed as theater; procyclical margining in a 50x world is unforgiving.

Commercially, CME’s stance is as strategic as it is legal. Exclusive benchmark licenses are a choke point; even if competitors secure approvals, pricing pipelines may still run through CME. Meanwhile, Coinbase gains a new regulatory bridge to a product it long dominated offshore, and Kalshi secures a first-mover slot for a domestic Bitcoin perp—a competitive shot at flow that traditionally accrues to CME. Acceleration by the CFTC compresses incumbents’ response time, which explains CME’s focus on process as well as substance.

Expect a multi-track contest: statutory interpretation of Dodd-Frank’s swap versus future definitions; scrutiny of the Commission’s review timeline; and parallel commercial fights over benchmark access. Practical signals to watch include how funding rates behave under U.S. risk controls, clearinghouse margin add-ons for perps, and whether index licensing becomes a bottleneck.

Duffy said he has spent eight months preparing the challenge with CME’s board and welcomed the fight. The timing coincides with a leadership transition: he will step down in March 2027, with President and CFO Lynne Fitzpatrick slated to become CME’s first female CEO. However the court rules, the market will quickly reprice liquidity, basis, and funding spreads as onshore perps meet U.S. rulebooks in real time.